| Application no. and date | 20200033.7 (espacenet) (Federated) (European Patent Register), 20170428 | | Patent/reg. no. and date | DK/EP 3782624, 20250910 | | Publication date | 20210224 | | Priority no. and date | DK PA201670281, 20160429 | | EP pub. no. and date |
EP 3782624 20210224 | | Effective date | | | Applicant/owner | Zevra Denmark A/S, Nordre Fasanvej 215, 2000 Frederiksberg, DK | | Applicant ref. no. | P3994DKEP01 | | Inventor | JENSEN, Thomas Kirkegaard, Rønneholmsvej 37, 2610 Rødovre, DK,
Fog-Tonnesen, Cathrine Kolster, Peder Godskes Vej 11, 2830 Virum, DK,
HINSBY, Anders Mørkeberg, Sømarksvej 4, 2900 Hellerup, DK,
PETERSEN, Nikolaj, Havnsøe, Torp, Viborggade 49, 1.th., 2100 København Ø, DK,
Bornæs, Claus, HøjsgÃ¥rds Allé 6, 2900 Hellerup, DK | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61K 45/06 (2006.01) , A61P 25/16 (2006.01) , A61P 25/28 (2006.01) , A61P 3/00 (2006.01) | | Title | Arimoclomol til behandling af glucocerebrosidase-associerede lidelser | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
